Nanoparticles and Biomaterials for Drug Delivery
A special issue of Journal of Functional Biomaterials (ISSN 2079-4983). This special issue belongs to the section "Biomaterials for Drug Delivery".
Deadline for manuscript submissions: closed (20 February 2024) | Viewed by 2744
Special Issue Editors
Interests: nanoparticles; biocompatible polymers; chitosan; drug carriers; pain; inflammation; experimental animal models; clinical trials
Special Issues, Collections and Topics in MDPI journals
Interests: anti-inflammatory drugs; depression; antidepressant drugs; biomarkers; drug delivery systems; in vivo animal models
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The advancement of nanomedicine is a medical priority today, with many countries developing new plans to improve research in this field. According to its extensive potential applications in medicine and in medical technologies more widely, the actual directions of nanomedicine advancement are represented by the development of basic science experiments in line with a multidisciplinary vision of nanoscience. Additionally, there is a need for training programs, especially for young researchers, and moreover to provide human resources to private industry.
Nanomedicine offers multiple interesting possibilities of nanotechnology application to significantly improve the development of preventive medicine, medical diagnosis, and therapeutic management.
The applications of nanotechnology in substance delivery systems development have opened up new areas of research in the sustained release of various drugs. Using diverse materials at the nanometer scale, nanotechnology will allow for specific and more personalized diagnosis and treatment of different pathologic areas such as cardiovascular diseases, cancer, inflammatory diseases, neurodegenerative syndromes such as Alzheimer’s or Parkinson’s disease, and psychiatric disturbances. Nanoparticle drug carriers consist of solid biodegradable particles ranging in size from 0.1 to 100 nm in which the active principle is dissolved, entrapped or encapsulated, and/or to which the active principle is absorbed or attached. The important technological advantages of nanoparticles used as drug carriers are high stability, high carrier capacity, a feasibility of incorporation of both hydrophilic and hydrophobic substances, and a feasibility of variable routes of administration. Due to their size, nanoparticles have the advantage of reaching otherwise less accessible sites in the body.
We invite researchers to submit original research articles and review articles. These can focus on a variety of issues, such as the obtention, characterization, structure, and original aspects about biomaterials for drug delivery. These articles will hopefully assist in uncovering novel design technologies, advantages, disadvantages, and their various medical applications.
Prof. Dr. Mititelu Tartau Liliana
Dr. Maria Bogdan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomaterials
- biocompatible polymers
- nanoparticles
- drug delivery
- structure–properties relationship
- biohybrid
- in vitro study
- biocompatibility evaluation
- in vivo animal models
- various applications of biomaterials
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
